Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies

Shahram Oveisgharan1,2, Lei Yu1,2, Ana Capuano1,2

  • 1Rush Alzheimer's Disease Center (S.O., L.Y., A.C., Z.A., L.L.B., J.A.S., D.A.B., A.S.B.), Rush University Medical Center, Chicago, IL.

Stroke
|April 12, 2021
PubMed

Insights

The general cardiovascular Framingham Risk Score (FRS) is linked to increased odds of some cerebrovascular disease (CVD) pathologies in older adults. However, FRS shows low accuracy in predicting individual CVD pathologies.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • The Framingham Risk Score (FRS) is a widely used tool for assessing cardiovascular disease risk.
  • Cerebrovascular disease (CVD) encompasses a range of conditions affecting the brain's blood vessels.
  • Understanding risk factors for CVD pathologies is crucial for preventative strategies.

Purpose of the Study:

  • To investigate the association between the baseline Framingham Risk Score (FRS) and the presence of postmortem cerebrovascular disease (CVD) pathologies.
  • To determine if FRS can predict specific types of CVD pathologies in older adults.

Main Methods:

  • Analysis of postmortem brain tissue from 1672 older decedents with available baseline FRS.
  • Quantification of CVD pathologies including macroinfarcts, microinfarcts, atherosclerosis, arteriolosclerosis, and cerebral amyloid angiopathy.
  • Logistic regression models were used to assess the relationship between FRS and each CVD pathology.

Main Results:

  • A higher baseline FRS was significantly associated with increased odds of macroinfarcts, microinfarcts, atherosclerosis, and arteriolosclerosis.
  • The predictive accuracy (C-statistics) of FRS for these CVD pathologies was low, ranging from 0.537 to 0.595.
  • No significant association was found between baseline FRS and the presence of cerebral amyloid angiopathy.

Conclusions:

  • Elevated FRS in older adults correlates with a higher likelihood of certain CVD pathologies but not all.
  • The current FRS demonstrates limited ability to accurately predict individual CVD pathologies at the postmortem level.
  • Development of more precise risk assessment tools is necessary for identifying individuals susceptible to accumulating CVD pathologies.
Abstract